Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 Next >
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Tags Eisai Co Ltd Health care industry Earnings
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags stocks Abbvie Inc Stock markets
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business News Biogen Inc Investing
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
Tags Netflix Inc Investment strategy Live Nation Entertainment Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology Boeing Co Eisai Co Ltd
From CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Health care industry Eisai Co Ltd Biotech and Pharmaceuticals
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Tags Pharmaceuticals Business Breaking news
From CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
Tags Biogen Inc Biotechnology US: News
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Health & Science Business News US: News
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Mad Money Eli Lilly and Co Eisai Co Ltd
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
Tags U/S/ Markets Business News Fidelis Insurance Holdings Ltd
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
Tags Business Pharmaceuticals Breaking news
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Business Mattel Inc
From CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Tags Health & Science Business News US: News
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Tags Health & Science Biotech and Pharmaceuticals Biogen Inc
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Tags Biogen Inc Biotechnology US: News
From CNBC.com News
5 things to know before the stock market opens Monday
Tags PepsiCo Inc/ Tesla Inc Economy
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Tags Science Business Pharmaceuticals
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Biogen Inc Biotechnology US: News
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business 5 Things to Know Walt Disney Co
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags Eisai Co Ltd Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Business News Health & Science Biogen Inc
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Exxon Mobil Corp Earnings Xpeng Inc
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags Progressive Corp Sherwin/Williams Co Raytheon Technologies Corp
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Biotech and Pharmaceuticals Health & Science Business News
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Business 5 Things to Know Morgan Stanley
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Eli Lilly and Co Eisai Co Ltd Health care industry
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Alzheimer's disease Business Science
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Biotech and Pharmaceuticals Regulations Eisai Co Ltd
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.